ANI Pharmaceuticals Inc (ANIP): Cost of Revenue
Older than the company's other figures. The latest Cost of Revenue is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$87.16M
Year ended 2020-12-31
+3.3%
3-year compound annual growth
+47.0%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2020-12-31 | $87.16M | +38.0% | 2021-03-11, From 2020-01-01 |
| 2019-12-31 | $63.15M | -13.5% | 2021-03-11, From 2019-01-01 |
| 2018-12-31 | $73.02M | -7.6% | 2021-03-11, From 2018-01-01 |
| 2017-12-31 | $79.03M | +62.0% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $48.78M | +284.3% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $12.69M | +10.6% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $11.47M | +15.0% | 2017-03-02, From 2014-01-01 |
| 2013-12-31 | $9.97M | +8.8% | 2016-02-23, From 2013-01-01 |
| 2012-12-31 | $9.17M | n/a | 2014-02-28, From 2012-01-01 |